Sign in
4

Changes in Ownership

ARROWHEAD PHARMACEUTICALS, INC. Filed Acc 0001181431-10-042237

Options or other derivatives

  • President and CEO acquired 500,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Anzalone Christopher Richard · President and CEO

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2010-08-16 Grant or award : show line 1 in the form Stock Option +500,000 2,214,750 D
Loading xslF345X03/rrd283979.xml…